During the past decade, Spectrum Health conducted 114 clinical trials. In the 10-year time frame, 114 clinical trials started and 49 clinical trials were completed, i.e. on average, 43% percent of trials that started reached the finish line to date. In the past 5 years, 47 clinical trials started and 31 clinical trials were completed. i.e. 66% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Spectrum Health" #1 sponsor was "Spectrum Health Hospitals" with 26 trials, followed by "Medtronic Cardiovascular" with 12 trials sponsored, "Boston Scientific Corporation" with 9 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 7 trials sponsored and "Abbott Medical Devices" with 7 trials sponsored. Other sponsors include 133 different institutions and companies that sponsored additional 106 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spectrum Health" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 5 trials as a collaborator, "Spectrum Health Hospitals" with 5 trials as a collaborator, "Van Andel Research Institute" with 4 trials as a collaborator, "Emory University" with 3 trials as a collaborator and "Genentech, Inc." with 3 trials as a collaborator. Other collaborators include 135 different institutions and companies that were collaborators in the rest 131 trials.

According to Clinical.Site data, the most researched conditions in "Spectrum Health" are "Coronary Artery Disease" (11 trials), "Atrial Fibrillation" (8 trials), "Heart Failure" (7 trials), "Breast Cancer" (6 trials) and "Aortic Valve Stenosis" (4 trials). Many other conditions were trialed in "Spectrum Health" in a lesser frequency.

Most popular intervention types in "Spectrum Health" are "Device" (89 trials), "Drug" (67 trials), "Other" (19 trials), "Procedure" (19 trials) and "Biological" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)" (4 trials), "Surgical Aortic Valve Replacement (SAVR)" (3 trials), "mavacamten" (3 trials) and "Aspirin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Spectrum Health" are 184 trials for "All" genders and 13 trials for "Female" genders.

Currently, there are NaN active trials in "Spectrum Health". undefined are not yet recruiting, 38 are recruiting, 29 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 93 completed trials in Spectrum Health, undefined suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Spectrum Health, 6 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 78 trials that are defined as “Not Applicable".